Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AAN 2022 | Blood biomarkers for the diagnosis of Alzheimer’s disease

Oscar López • 4 Apr 2022
AAN 2022
Alzheimer’s Disease Dementia

Oscar López, MD, FAAN, University of Pittsburgh, Pittsburgh, PA, discusses the use of blood-based biomarkers in the diagnosis of Alzheimer’s disease and talks on the possibility of a blood test being used in the future for the diagnosis of early-stage dementia. This interview took place at the American Academy of Neurology 2022 Congress in Seattle, WA.

More from Oscar López

1:26
Predictive factors of progression from mild cognitive impairment to dementia
Oscar López • 4 Apr 2022
1:35
Diagnosing mild cognitive impairment
Oscar López • 4 Apr 2022
1:14
Potential of anti-amyloid drugs for treating Alzheimer's disease
Oscar López • 4 Apr 2022

Related Videos

2:33
Anti-amyloid therapy for Alzheimer's disease: beyond the 18-month mark
Dorota Religa • 22 Mar 2024
0:50
Will long-term anti-amyloid treatment show greater clinical benefit?
Dorota Religa • 22 Mar 2024
1:24
Digital frailty screening in dementia
Dorota Religa • 22 Mar 2024
4:19
Current projects from Alzheimer’s Disease International
Paola Barbarino • 23 Mar 2024
The content of VJDementia is intended for healthcare professionals